Ladenburg Thalmann Financial Services’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-100
| Closed | – | – | 5622 |
|
|
2018
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 5250 |
|
|
2018
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 5390 |
|
|
2017
Q4 | $0 | Buy |
100
+90
| +900% | – | ﹤0.01% | 5304 |
|
|
2017
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 5225 |
|
|
2017
Q2 | $0 | Sell |
10
-500
| -98% | – | ﹤0.01% | 5171 |
|
|
2017
Q1 | $2K | Buy |
510
+500
| +5,000% | +$1.96K | ﹤0.01% | 4657 |
|
|
2016
Q4 | $0 | Sell |
10
-25
| -71% | – | ﹤0.01% | 5146 |
|
|
2016
Q3 | $0 | Sell |
35
-50
| -59% | – | ﹤0.01% | 5102 |
|
|
2016
Q2 | $0 | Buy |
85
+50
| +143% | – | ﹤0.01% | 5083 |
|
|
2016
Q1 | $0 | Hold |
35
| – | – | ﹤0.01% | 5068 |
|
|
2015
Q4 | $0 | Hold |
35
| – | – | ﹤0.01% | 5018 |
|
|
2015
Q3 | $1K | Sell |
35
-43
| -55% | -$1.23K | ﹤0.01% | 4575 |
|
|
2015
Q2 | $4K | Hold |
78
| – | – | ﹤0.01% | 4203 |
|
|
2015
Q1 | $6K | Sell |
78
-108
| -58% | -$8.31K | ﹤0.01% | 3940 |
|
|
2014
Q4 | $11K | Buy |
186
+161
| +644% | +$9.52K | ﹤0.01% | 3402 |
|
|
2014
Q3 | $1K | Sell |
25
-15
| -38% | -$600 | ﹤0.01% | 3901 |
|
|
2014
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 3728 |
|
|
2014
Q1 | $3K | Buy |
40
+15
| +60% | +$1.13K | ﹤0.01% | 3479 |
|
|
2013
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 3712 |
|
|
2013
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 3522 |
|
|
2013
Q2 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 3594 |
|